Robert Iannone

CIK 1737329 · EVP, Global Head of R&D & CMO · last filed 2026-03-09

Robert Iannone is an EVP, Global Head of R&D & CMO who has filed 35 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing shows the insider had shares withheld for taxes covering $1.2M of JAZZ on Mar 9, 2026. Across all open-market trades the lifetime net is −$2.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $20.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$20.49M

Companies

4

Total Filings

35

Lifetime Open-Market Net

-$2.80M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
JAZZ EVP, Global Head of R&D & CMO 88,871 $230.56 $20.49M -$2.80M 22 2026-03-09
iTeos Therapeutics, Inc. (ITOS) Delisted Director $10.15 $0 5 2024-06-13
Jounce Therapeutics, Inc. (JNCE) Delisted Director $1.88 $0 6 2023-05-04
IMMUNOMEDICS INC (IMMU) Delisted CHIEF MEDICAL OFFICER $0 2 2019-03-18

Recent Filings

35 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-03-09 JAZZ Tax (F) −6,209 -$1.17M EDGAR
2026-03-02 JAZZ Grant (A) +14,822 $0 EDGAR
2026-01-21 JAZZ Mixed +7,559 -$708.6K EDGAR
2025-11-19 JAZZ Sell (S) −7,159 -$1.20M EDGAR
2025-03-12 JAZZ Sell (S) −2,403 -$332.6K EDGAR
2025-03-07 JAZZ Mixed −12,319 -$1.71M EDGAR
2025-03-03 JAZZ Grant (A) +26,577 $0 EDGAR
2025-01-22 JAZZ Mixed +5,325 -$267.4K EDGAR
2024-06-13 iTeos Therapeutics, Inc. (ITOS) Delisted Grant (A) $0 EDGAR
2024-03-07 JAZZ Tax (F) −4,294 -$504.7K EDGAR
Showing 110 of 35
Page 1 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.